Patents by Inventor Lishomwa C. Ndhlovu

Lishomwa C. Ndhlovu has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Anti-galectin-9 antibody and methods of use thereof
    Patent number: 11912772
    Abstract: An antibody targeting Galectin-9 is provided as are methods of using the same treatment of chronic immune conditions such as infections, inflammatory diseases and cancer, in particular malignant mesothelioma.
    Type: Grant
    Filed: July 12, 2019
    Date of Patent: February 27, 2024
    Assignee: University of Hawaii
    Inventors: Lishomwa C. Ndhlovu, Toshiro Niki
  • Methods for inhibiting HIV or HCV infection by administering TIM-3 binding inhibitors
    Patent number: 11261231
    Abstract: The application relates to methods of treating chronic viral infection by modulating Tim-3 activity. In addition, the present application relates to methods of diagnosing or monitoring immune system activity or function, chronic viral infection and inflammatory disease using Tim-3 expression.
    Type: Grant
    Filed: July 13, 2016
    Date of Patent: March 1, 2022
    Assignees: Altor BioScience, LLC., The Regents of the University of Califoria
    Inventors: Richard B. Jones, Mario Ostrowski, Douglas F. Nixon, Lishomwa C. Ndhlovu, James Rini
  • ANTI-GALECTIN-9 ANTIBODY AND METHODS OF USE THEREOF
    Publication number: 20210324086
    Abstract: An antibody targeting Galectin-9 is provided as are methods of using the same treatment of chronic immune conditions such as infections, inflammatory diseases and cancer, in particular malignant mesothelioma.
    Type: Application
    Filed: July 12, 2019
    Publication date: October 21, 2021
    Inventors: Lishomwa C. NDHLOVU, Toshiro NIKI
  • Therapeutic and Diagnostic Methods Using TIM-3
    Publication number: 20160311890
    Abstract: The application relates to methods of treating chronic viral infection by modulating Tim-3 activity. In addition, the present application relates to methods of diagnosing or monitoring immune system activity or function, chronic viral infection and inflammatory disease using Tim-3 expression.
    Type: Application
    Filed: July 13, 2016
    Publication date: October 27, 2016
    Inventors: Richard B. Jones, Mario Ostrowski, Douglas F. Nixon, Lishomwa C. Ndhlovu, James Rini
  • Methods of inhibiting viral replication and improving T cell function employing soluble Tim-3 inhibitors
    Patent number: 9416165
    Abstract: The application relates to methods of treating a chronic viral infection, such as HIV (Human Immunodeficiency Virus), by modulating Tim-3 activity, whereby blocking the action of Tim-3 on a T cell enhances the immunity to the virus.
    Type: Grant
    Filed: October 27, 2008
    Date of Patent: August 16, 2016
    Assignees: The Regents of the University of California
    Inventors: Richard B. Jones, Mario Ostrowski, Douglas F. Nixon, Lishomwa C. Ndhlovu, James Rini
  • Therapeutic and Diagnostic Methods Using TIM-3
    Publication number: 20100247521
    Abstract: The application relates to methods of treating chronic viral infection by modulating Tim-3 activity. In addition, the present application relates to methods of diagnosing or monitoring immune system activity or function, chronic viral infection and inflammatory disease using Tim-3 expression.
    Type: Application
    Filed: October 27, 2008
    Publication date: September 30, 2010
    Inventors: Richard B. Jones, Mario Ostrowski, Douglas F. Nixon, Lishomwa C. Ndhlovu, James Rini